— Know what they know.
Not Investment Advice
Also trades as: FBIO (NASDAQ) · $vol 1M

FBIOP NASDAQ

Fortress Biotech, Inc.
1W: +1.4% 1M: -9.8% 3M: -16.6% YTD: +66.1% 1Y: +124.5% 3Y: +46.7% 5Y: -12.3%
$16.86
+0.80 (+4.98%)
 
Weekly Expected Move ±3.6%
$16 $16 $17 $17 $18
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 44 · $132.7M mcap · 5M float · 0.349% daily turnover · Short 22% of daily vol

Cash Flow Trends

Operating Cash Flow
-$80M +37.5% ▲
Capital Expenditures
$15M -85.2% ▼
5Y CAGR: +9.8%
Free Cash Flow
-$95M +30.2% ▲
Dividends Paid
$5M +46.3% ▲
Buybacks
$0 +100.0% ▲
Net Change in Cash
-$25M +74.8% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$103M-$165M-$214M-$154M-$121M
Depreciation & Amort.$5M$7M$9M$6M$4M
Stock-Based Comp.$13M$19M$23M$17M$33M
Change in Working Capital-$5M$36M-$715K-$13M-$8M
Other Non-Cash Items$5M-$14M$3M$15M$12M
Operating Cash Flow-$84M-$117M-$179M-$128M-$80M
— Investing Activities —
Capital Expenditures-$2M-$5M-$3M-$63K-$15M
Acquisitions (Net)$0$57M-$20M$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$5M-$12M-$213K-$2M$0
Investing Cash Flow-$7M$41M-$23M-$2M-$15M
— Financing Activities —
Net Debt Issuance-$30M-$10M$49M-$39M-$7M
Stock Repurchased-$70K$0-$1M$0$0
Dividends Paid-$7M-$9M-$9M-$9M-$5M
Other Financing-$9M-$5M-$7M-$529K-$163K
Financing Cash Flow$172M$149M$75M$33M$71M
Net Change in Cash$82M$73M-$127M-$98M-$25M
Cash End of Period$235M$308M$181M$83M$59M
Free Cash Flow-$91M-$133M-$182M-$136M-$95M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms